Species-specific differences in hepatic mutant frequency and mutational spectrum among lambda/lac1 transgenic rats and mice following exposure to aflatoxin B1

Carcinogenesis

Volumn 17, Issue 11, 1996, Pages 2347-2356

  Dycaico, M J ^a   Stuart, G R ^b   Tobal, G M ^a   De Boer, J G ^b   Glickman, B W ^b   Provost, G S ^a  

^a Stratagene   (United States)

^b UNIVERSITY OF VICTORIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AFLATOXIN B1; DIMETHYL SULFOXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DNA SEQUENCE; LIVER CARCINOGENESIS; MOUSE; MUTATION RATE; NONHUMAN; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL; RAT; RISK ASSESSMENT; SHUTTLE VECTOR; SPECIES DIFFERENCE; SPONTANEOUS MUTATION; TRANSGENIC ANIMAL;

EID: 0029822465     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/17.11.2347     Document Type: Article

References (51)

1. Kohler, S.W., Provost, G.S. Fieck, A., Kretz, P.L., Bullock, W.O., Putman, D.L., Sorge, J.A. and Short, J.M. (1991a) Analysis of spontaneous and induced mutations in transgenic mice using a lambda ZAP/lacI shuttle vector. Environ. Mol. Mutagen., 18, 316-321.
2. Kohler, S.W., Provost, G.S., Fieck, A., Kretz, P.L., Bullock, W.O., Sorge, J.A., Putman, D.L. and Short, J.M. (1991b) Spectra of spontaneous and mutagen-induced mutations in the lacI gene in transgenic mice. Proc. Natl Acad. Sci. USA, 88, 7958-7962.
3. Provost, G.S., Kretz, P.L., Hamner, R.T., Matthews, C.D., Rogers, B.J., Lundberg, K.S., Dycaico, M.J. and Short, J.M. (1993) Transgenic systems for in vivo mutation analysis. Mutat. Res., 288, 133-149.
4. Gorelick, N.J. (1995) Overview of mutation assays in transgenic mice for routine testing. Environ. Mol. Mutagen., 25, 218-230.
5. Dycaico, M.J., Provost, G.S., Kretz, P.L., Ransom, S.L., Moores, J.C. and Short, J.M. (1994) The use of shuttle vectors for mutation analysis in transgenic mice and rats. Mutat. Res., 307, 461-478.
6. Newberne, P.M. and Butler, W.H. (1969) Acute and chronic effects of aflatoxin on the liver of domestic and laboratory animals: A review. Cancer Res., 29, 236-250.
7. Wogan, G.N. (1973) Aflatoxin carcinogenesis. In Busch, H. (ed.), Methods in cancer research. Academic Press, New York, vol. 7, pp. 309-344.
8. Eaton, D.L. and Groopman, J.D. (1994) The Toxicology of Aflatoxins: Human Health, Veterinary and Agricultural Significance. Academic Press, Inc., San Diego, CA.
9. Eaton, D.L. and Gallagher, E.P. (1994) Mechanisms of aflatoxin carcinogenesis. Annu. Rev. Pharmacol. Toxicol., 34, 135-172.
10. 1 carcinogenicity. Proc. Soc. Exp. Biol. Med., 208, 213-227.
11. Ross, R.K., Yuan, J.M., Yu, M.C., Wogan, G.N., Qian, G.S., Tu, J.T., Groopman, J.D., Gao, Y.T. and Henderson, B.E. (1992) Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma. Lancet, 339, 943-946.
12. World Health Organization (1993) IARC Monographs on the Evaluation of the Carcinogenic Risks to Humans. Some Naturally Occurring Substances: Food Items and Constituents, Heterocyclic Amines and Mycotoxins. IARC Scientific Publications, Lyon, France, vol. 56, pp. 245-395.
13. Coursaget, P., Depril, N., Chabaud, M., Nandi, R., Mayelo, V., LeCann, P. and Yvonnet, B. (1993) High prevalence of mutations at codon 249 of the p53 gene in hepatocellular carcinomas from Senegal. Br. J. Cancer, 67, 1395-1397.
14. Aguilar, F., Harris, C.C., Sun, T., Hollstein, M. and Cerutti, P. (1994) Geographic variation of p53 mutational profile in nonmalignant human liver. Science, 264, 1317-1319.
15. th Annual Report on Carcinogens. Research Triangle Park, NC.
16. Busby, W.F. and Wogan, G.N. (1984) Aflatoxins. In Searle, C.E. (ed.), Chemical Carcinogens, 2nd Edn, vol. 2, ACS Monograph 182, American Chemical Society, Washington DC, Chapter 16, pp. 945-1136.
17. Hsu, I.C. Harris, C.C, Lipsky, M.M., Snyder, S. and Trump, B.F. (1987) Cell and species differences in metabolic activation of chemical carcinogens. Mutat. Res., 177, 1-7.
18. Van Ness, K.P., Buetler, T.M. and Eaton, D.L. (1994) Enzymatic characteristics of chimeric mYc/rYc1 glutathione S-transferases. Cancer Res., 54, 4573-1575.
19. Rogers, B.J., Provost, G.S., Young, R.R., Putman, D.L. and Short, J.M. (1995) Intralaboratory optimization and standardization of mutant screening conditions used for a lambda/lacI transgenic mouse mutagenesis assay (I). Mutat. Res., 327, 57-66.
20. ®) (II). Mutat. Res., 327, 67-73.
21. de Boer, J.G., Erfle, H., Holcroft, J., Walsh, D., Dycaico, M., Provost, S., Short, J. and Glickman, B.W. (1996). Spontaneous mutants recovered from liver and germ cell tissue of low copy number lacI transgenic rats. Mutat. Res., 352, 73-78.
22. de Boer, J.G. (1995) Software package for the management of sequencing projects using lacI transgenic animals. Environ. Mol. Mutagen., 25, 256-262.
23. Adams, W.T. and Skopek, T.R. (1987) Statistical test for the comparison of samples from mutational spectra. J. Mol. Biol., 194, 391-396.
24. McLean, M. and Dutton, M.F. (1995) Cellular interactions and metabolism of aflatoxin: An update. Pharmacol. Ther., 65, 163-192.
25. 1 in vitro. Proc. Natl Acad. Sci. USA, 74, 1870-1874.
26. Raney, V.M., Harris, T.M. and Stone, M.P. (1993) DNA conformation mediates aflatoxin B1-DNA binding and the formation of guanine N7 adducts by aflatoxin B1 8,9-exo-epoxide. Chem. Res. Toxicol., 6, 64-68.
27. 1-DNA adduct. Proc. Natl Acad. Sci. USA, 93, 1535-1539.
28. 1. Pharmacol. Ther., 50, 443-472.
29. 1-8,9-epoxide conjugating activities of two bacterially expressed alpha class glutathione S-transferase isozymes from mouse and rat. Biochem. Biophys. Res. Commun., 188, 597-603.
30. 1. J. Biol. Chem., 269, 20707-20717.
31. 1 by different species. Risk Analysis, 10, 539-559.
32. Wogan, G.N. (1992) Aflatoxin carcinogenesis: Interspecies potency differences and relevance for human risk assessment. Prog. Clin. Biol. Res., 374, 123-137.
33. Lee, A.T., DeSimone, C., Cerami, A. and Bucala, R. (1994) Comparative analysis of DNA mutations in lacI transgenic mice with age. FASEB J., 8, 545-550.
34. Baker, H.J. Lindsey, J.R. and Weisbroth, S.H. (1979) Appendix 1: Selected normative data. In Baker, H.J., Lindsey, J.R. and Weisbroth, S.H. (eds), The Laboratory Rat. Academic Press, Inc., San Diego, CA, vol. I. p. 411.
35. Croy, R.G. and Wogan, G.N. (1981) Quantitative comparison of covalent aflatoxin-DNA adducts formed in rat and mouse livers and kidneys. J. Natl Cancer Inst., 66, 761-768.
36. 1. Proc. Natl Acad. Sci. USA, 80, 2695-2698.
37. 1-induced mutations in a plasmid replicated in xeroderma pigmentosum and DNA repair proficient human cells. Cancer Res., 52, 5668-5673.
38. Sambamurti, K., Callahan, J., Luo, X., Perkins, C.P., Jacobson, J.S. and Humayun, M.Z. (1988) Mechanisms of mutagenesis by a bulky DNA lesion at the guanine N7 position. Genetics, 120, 863-873.
39. Sahasrabudhe, S., Sambamurti, K. and Humayun, M.Z. (1989) Mutagenesis by aflatoxin in M13 DNA: Base-substitution mechanisms and the origin of strand bias. Mol. Gen. Genet., 217, 20-25.
40. Tudek, B., Boiteux, S. and Laval, J. (1992) Biological properties of imidazole ring-opened N7-methylguanine in M13mp18 phage DNA. Nucleic. Acids Res., 20, 3079-3084.
41. Sagher, D. and Strauss, B. (1983) Insertion of nucleotides opposite apurinic/ apyrimidinic sites in deoxyribonucleic acid during in vitro synthesis: Uniqueness of adenine nucleotides. Biochemistry, 22, 4518-4526.
42. Neto, J.B., Gentil, A., Cabral, R.E. and Sarasin, A. (1992) Mutation spectrum of heat-induced abasic sites on a single-stranded shuttle vector replicated in mammalian cells. J. Biol. Chem., 267, 19718-19723.
43. Marien, K., Moyer, R., Loveland, P., Van Holde, K. and Bailey, G. (1987) Comparative binding and sequence interaction specificities of aflatoxin B1, aflatoxicol, aflatoxin M1, and aflatoxicol M1 with purified DNA. J. Biol. Chem., 262, 7455-7462.
44. Benasutti, M., Ejadi, S., Whitlow, M.D. and Loechler, E.L. (1988) Mapping the binding site of aflatoxin B1 in DNA: Systematic analysis of the reactivity of aflatoxin B1 with guanines in different DNA sequences. Biochemistry, 27, 472-481.
45. Misra, R.P., Muench, K.F. and Humayun, M.Z. (1983) Covalent and noncovalent interactions of aflatoxin with defined deoxyribonucleic acid sequences. Biochemistry, 22, 3351-3359.
46. 1 in the human hypoxanthine guanine phosphoribosyltransferase gene. Cancer Res., 54, 4436-4441.
47. McMahon, G., Davis, E.F., Huber, L.J., Kim, Y. and Wogan, G.N. (1990) Characterization of c-Ki-ras and N-ras oncogenes in aflatoxin B1-induced rat liver tumors. Proc. Natl Acad. Sci. USA, 87, 1104-1108.
48. 1. Mol. Carcinogenesis, 4, 112-119.
49. Hsu, I.C., Metcalf, R.A., Sun, T., Welsh, J.A., Wang, N.J. and Harris, C.C. (1991) Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature (Lond.), 350, 427-428.
50. Bressac, B., Kew, M., Wands, J. and Ozturk, M. (1991) Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature (Lond.), 350, 429-431.
51. Farabaugh, P.J. (1978) Sequence of the lacI gene. Nature, 274, 765-769.